Woodward ER - Search Results

1

Prevalence of germline pathogenic BRCA1/2 variants in sequential epithelial ovarian cancer cases.

Morgan RD, Burghel GJ, Flaum N, Bulman M, Clamp AR, Hasan J, Mitchell CL, Schlecht H, Woodward ER, Lallo FI, Crosbie EJ, Edmondson RJ, Wallace AJ, Jayson GC, Evans DGR. Morgan RD, et al. Among authors: woodward er. J Med Genet. 2019 May;56(5):301-307. doi: 10.1136/jmedgenet-2018-105792. Epub 2019 Jan 25. J Med Genet. 2019. PMID: 30683677

2

Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening.

Smith A, Moran A, Boyd MC, Bulman M, Shenton A, Smith L, Iddenden R, Woodward ER, Lalloo F, Maher ER, Evans DG. Smith A, et al. Among authors: woodward er. J Med Genet. 2007 Jan;44(1):10-15. doi: 10.1136/jmg.2006.043091. Epub 2006 Nov 1. J Med Genet. 2007. PMID: 17079251 Free PMC article.

3

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family.

Evans DG, Shenton A, Woodward E, Lalloo F, Howell A, Maher ER. Evans DG, et al. Among authors: woodward e. BMC Cancer. 2008 May 30;8:155. doi: 10.1186/1471-2407-8-155. BMC Cancer. 2008. PMID: 18513387 Free PMC article.

4

Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.

Byrd LM, Shenton A, Maher ER, Woodward E, Belk R, Lim C, Lalloo F, Howell A, Jayson GC, Evans GD. Byrd LM, et al. Among authors: woodward e. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1535-42. doi: 10.1158/1055-9965.EPI-07-2792. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559571 Free article.

5

Tumor risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD.

Ricketts CJ, Forman JR, Rattenberry E, Bradshaw N, Lalloo F, Izatt L, Cole TR, Armstrong R, Kumar VK, Morrison PJ, Atkinson AB, Douglas F, Ball SG, Cook J, Srirangalingam U, Killick P, Kirby G, Aylwin S, Woodward ER, Evans DG, Hodgson SV, Murday V, Chew SL, Connell JM, Blundell TL, Macdonald F, Maher ER. Ricketts CJ, et al. Among authors: woodward er. Hum Mutat. 2010 Jan;31(1):41-51. doi: 10.1002/humu.21136. Hum Mutat. 2010. PMID: 19802898

6

Increased rate of phenocopies in all age groups in BRCA1/BRCA2 mutation kindred, but increased prospective breast cancer risk is confined to BRCA2 mutation carriers.

Evans DG, Ingham SL, Buchan I, Woodward ER, Byers H, Howell A, Maher ER, Newman WG, Lalloo F. Evans DG, et al. Among authors: woodward er. Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2269-76. doi: 10.1158/1055-9965.EPI-13-0316-T. Epub 2013 Nov 27. Cancer Epidemiol Biomarkers Prev. 2013. PMID: 24285840

7

Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens.

Evans DG, Lalloo F, Howell S, Verhoef S, Woodward ER, Howell A. Evans DG, et al. Among authors: woodward er. Breast Cancer Res Treat. 2016 Feb;155(3):597-601. doi: 10.1007/s10549-016-3697-z. Epub 2016 Feb 18. Breast Cancer Res Treat. 2016. PMID: 26888723

8

Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.

Smith J, Read ML, Hoffman J, Brown R, Bradshaw B, Campbell C, Cole T, Navas JD, Eatock F, Gundara JS, Lian E, Mcmullan D, Morgan NV, Mulligan L, Morrison PJ, Robledo M, Simpson MA, Smith VE, Stewart S, Trembath RC, Sidhu S, Togneri FS, Wake NC, Wallis Y, Watkinson JC, Maher ER, McCabe CJ, Woodward ER. Smith J, et al. Among authors: woodward er. Hum Mol Genet. 2016 May 1;25(9):1836-45. doi: 10.1093/hmg/ddw057. Epub 2016 Mar 3. Hum Mol Genet. 2016. PMID: 26945007

9

Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores.

Evans DG, Woodward ER, Howell SJ, Verhoef S, Howell A, Lalloo F. Evans DG, et al. Among authors: woodward er. Fam Cancer. 2017 Apr;16(2):173-179. doi: 10.1007/s10689-016-9942-0. Fam Cancer. 2017. PMID: 27796713 Free PMC article.

10

Pathology update to the Manchester Scoring System based on testing in over 4000 families.

Evans DG, Harkness EF, Plaskocinska I, Wallace AJ, Clancy T, Woodward ER, Howell TA, Tischkowitz M, Lalloo F. Evans DG, et al. Among authors: woodward er. J Med Genet. 2017 Oct;54(10):674-681. doi: 10.1136/jmedgenet-2017-104584. Epub 2017 May 10. J Med Genet. 2017. PMID: 28490612

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

372 results

Search Page

Filters